{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:08:03Z","timestamp":1788934083343,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.schres.2017.01.043","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T11:17:37Z","timestamp":1487243857000},"page":"126-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder"],"prefix":"10.1016","volume":"189","author":[{"given":"Marc","family":"Cantillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxminarayan","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2017.01.043_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.01.043_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.043_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006622.pub2","article-title":"Aripiprazole versus placebo for schizophrenia","volume":"8","author":"Belgamwar","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.schres.2017.01.043_bb0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1592\/phco.29.1.64","article-title":"Antipsychotic induced hyperprolactinemia","volume":"29","author":"Bostwick","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.schres.2017.01.043_bb0025","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0920-9964(14)70070-2","article-title":"Efficacy and safety of novel dopamine serotonin stabilizer RP5063 in acute schizophrenia and schizoaffective disorder","volume":"153","author":"Cantillon","year":"2014","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2017.01.043_bb0030","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1176\/appi.ajp.2012.12010123","article-title":"Initial validity and reliability data on the Columbia-Suicide Severity Rating Scale","volume":"169","author":"Chappell","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.043_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fnint.2015.00067","article-title":"Sequential astrocytic 5-HT2B receptor stimulation, [Ca2+]i regulation, glycogenolysis, glutamate synthesis, and K+ homeostasis are similar but not identical in learning and mood regulation","volume":"9","author":"Chen","year":"2016","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.schres.2017.01.043_bb0040","series-title":"Pharmacotherapy: A Pathophysiologic Approach","first-page":"1019","article-title":"Schizophrenia","author":"Crismon","year":"2014"},{"issue":"1","key":"10.1016\/j.schres.2017.01.043_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0973-1229.91588","article-title":"Treatment-resistant schizophrenia: evidence-based strategies","volume":"10","author":"Englisch","year":"2012","journal-title":"Mens Sana Monogr."},{"key":"10.1016\/j.schres.2017.01.043_bb0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fncel.2013.00102","article-title":"Dopamine, cognitive function, and gamma oscillations: role of D4 receptors","volume":"7","author":"Furth","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.schres.2017.01.043_bb0055","series-title":"ECDEU Assessment Manual for Psychopharmacology (Revised). US Department of Health, Education, and Welfare Publication (ADM) 76\u2013338","first-page":"193","author":"Guy","year":"1976"},{"issue":"suppl","key":"10.1016\/j.schres.2017.01.043_bb0060","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2152\/jmi.52.284","article-title":"Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist","volume":"52","author":"Hirose","year":"2005","journal-title":"J. Med. Investig."},{"key":"10.1016\/j.schres.2017.01.043_bb0065","series-title":"Positive and Negative Syndrome Scale (PANSS) Rating Criteria","author":"Kay","year":"1999"},{"issue":"1","key":"10.1016\/j.schres.2017.01.043_bb0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.109.160432","article-title":"Cariprazine (RGH-188), a dopamine D3 receptor-preferring, D3\/D2 dopamine receptor antagonist\u2013partial agonist antipsychotic candidate: in vitro and neurochemical profile","volume":"333","author":"Kiss","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.schres.2017.01.043_bb0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1517\/14728214.2014.958148","article-title":"Emerging drugs for schizophrenia: an update","volume":"19","author":"Koester","year":"2014","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"Suppl. 7","key":"10.1016\/j.schres.2017.01.043_bb0080","first-page":"32","article-title":"The clinical implications of weight gain in schizophrenia","volume":"62","author":"Kurzthaler","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.043_bb0085","article-title":"RP5063 reverses and prevents subchronic phencyclidine-induced declarative memory deficits and increases cortical dopamine efflux in C57BL\/6J mice","author":"Kwon","year":"2015","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.schres.2017.01.043_bb0090","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/jpet.114.213793","article-title":"Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulators","volume":"350","author":"Maeda","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2017.01.043_bb0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.npp.1300057","article-title":"Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders","volume":"28","author":"Marek","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.schres.2017.01.043_bb0100","first-page":"1047","article-title":"Antipsychotics and hyperprolactinemia: prevalence and risk factors","volume":"3","author":"Marrag","year":"2015","journal-title":"Ann Psychiatry Ment Health."},{"key":"10.1016\/j.schres.2017.01.043_bb0105","first-page":"1163","article-title":"Altamura AC clinical pharmacology of atypical antipsychotics","volume":"13","author":"Mauri","year":"2014","journal-title":"EXCLI J."},{"issue":"2","key":"10.1016\/j.schres.2017.01.043_bb0110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1124\/jpet.106.102905","volume":"318","author":"Natesan","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2017.01.043_bb0115","first-page":"5","article-title":"Pharmacology of \u201catypicality\u201d of antipsychotic drugs: status and perspectives","volume":"4","author":"Newman-Tancredi","year":"2010","journal-title":"Arch Psychiatr Psychother."},{"key":"10.1016\/j.schres.2017.01.043_bb0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-015-0236-0","article-title":"Targeting the serotonin 5-HT7 receptor in the search for treatments for CNS disorders: rationale and progress to date","volume":"29","author":"Nikiforuk","year":"2015","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.schres.2017.01.043_bb0125","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.043_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"2","key":"10.1016\/j.schres.2017.01.043_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","article-title":"Trail making test A and B: normative data stratified by age and education","volume":"19","author":"Tombaugh","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.schres.2017.01.043_bb0140","series-title":"The Measurement of Adult Intelligence","author":"Wechsler","year":"1939"},{"key":"10.1016\/j.schres.2017.01.043_bb9000","series-title":"Mental Health: Schizophrenia","author":"World Health Organization","year":"2013"},{"issue":"23","key":"10.1016\/j.schres.2017.01.043_bb0145","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1523\/JNEUROSCI.1187-05.2005","article-title":"Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism","volume":"25","author":"Yuen","year":"2005","journal-title":"J. Neurosci."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417300567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996417300567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T08:25:26Z","timestamp":1536049526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996417300567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":30,"alternative-id":["S0920996417300567"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.043","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}